Results 11 to 20 of about 24,968 (201)
Asbestos and Intrahepatic Cholangiocarcinoma [PDF]
Cells, 2020 The link between asbestos exposure and the onset of thoracic malignancies is well established. However epidemiological studies have provided evidences that asbestos may be also involved in the development of gastrointestinal tumors, including intrahepatic cholangiocarcinoma (ICC). In line with this observation, asbestos fibers have been detected in the
Simona Tavolari +2 more
exaly +4 more sources
Intrahepatic Cholangiocarcinoma [PDF]
Surgical Oncology Clinics of North America, 2014 Intrahepatic cholangiocarcinoma (ICC) is a rare tumor, with an increasing incidence worldwide and an overall poor prognosis. Symptoms are usually nonspecific, contributing to an advanced tumor stage at diagnosis. The staging system for ICC has recently been updated and is based on number of lesions, vascular invasion, and lymph node involvement ...
Kimberly M, Brown +2 more
+5 more sources
An extremely rare case of intrahepatic sarcomatoid cholangiocarcinoma
Radiology Case Reports, 2023 One uncommon histological subtype of intrahepatic cholangiocarcinoma is sarcomatoid intrahepatic cholangiocarcinoma. Histopathological and immunohistochemical tests are used to diagnose sarcomatoid intrahepatic cholangiocarcinoma, which frequently has a ...
Dau Quang Lieu, MD +4 more
doaj +1 more source
Sarcomatoid Intrahepatic Cholangiocarcinoma: A Case Report [PDF]
Advanced Ultrasound in Diagnosis and Therapy, 2023 Conventional two-dimensional ultrasonography revealed a hypoechoic mass in the liver of a middle-aged male patient. Enhanced ultrasound suggested intrahepatic cholangiocarcinoma. Enhanced MRI confirmed it as liver cancer.
Cuiwei Wang, MD, Xin-Hua Ye, MD
doaj +1 more source
Frontiers in Immunology, 2021 Advanced intrahepatic cholangiocarcinoma (iCCA) is not suitable for surgical treatment. Guided by the concept of precision medicine, preoperative systematic treatment may reshape the clinical outcomes of advanced intrahepatic cholangiocarcinoma patients.
Ze Zhang +14 more
doaj +1 more source
World Journal of Surgical Oncology, 2022 Objective To systematically evaluate the relationship between vascular endothelial growth factor (VEGF) and prognosis of intrahepatic cholangiocarcinoma by meta-analysis.
Chunping Cai +3 more
doaj +1 more source
Intrahepatic Cholangiocarcinoma
Seminars in Interventional Radiology, 2020 AbstractCholangiocarcinoma is the second most common primary malignancy of the liver. This review will focus on the mass-forming intrahepatic type of this disease and discuss the role of medical, surgical, and radiation oncology in managing this difficult disease.
Pouya, Entezari, Ahsun, Riaz
openaire +4 more sources
Management of Intrahepatic Cholangiocarcinoma [PDF]
Journal of Clinical Medicine, 2021 Cholangiocarcinoma is a tumor that arises as a result of differentiation of the cholangiocytes and can develop from anywhere in the biliary tree. Subtypes of cholangiocarcinoma are differentiated based on their location in the biliary tree. If diagnosed early these can be resected, but most cases of intrahepatic cholangiocarcinoma present late in the ...
Sudha Kodali +4 more
openaire +2 more sources
Journal of Hematology & Oncology, 2022 Background Immunotherapy has demonstrated a limited clinical efficacy in approximately 5% of cholangiocarcinoma. The main challenges for an effective immunotherapy response in cholangiocarcinoma arise from the tumor microenvironment, which is poorly ...
Tao Xia +17 more
doaj +1 more source
BMC Cancer, 2021 Background Cholangiocarcinoma is a common malignant tumor of digestive system. LncRNA metallothionein 1 J, pseudogene (MT1JP) has been reported to play tumor-suppressing roles in multiple cancers.
Wei Zhao +5 more
doaj +1 more source